Emese Zsiros
- Roswell Park Comprehensive Cancer Center (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #26,935
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14836740Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$663.8K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#26,935
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Emese Zsiros as a PI. Multi-PI records show the full award amount for context.
- 5R01CA267690-05R01Contact PITargeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer$663.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Emese Zsiros as a PI.
FY2026 award administered by Roswell Park Comprehensive Cancer Center (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardRoswell Park Comprehensive Cancer Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Emese Zsiros.